<DOC>
	<DOCNO>NCT02990546</DOCNO>
	<brief_summary>The aim study investigate role oral midodrine recovery septic shock . The investigator hypothesize oral drug reduce central line day ICU length stay .</brief_summary>
	<brief_title>Midodrine Recovery Phase Septic Shock</brief_title>
	<detailed_description>The investigator aim investigate use midodrine recovery phase septic shock randomize control trial . The investigator hypothesize midodrine use initiate stabilization improve intravenous vasopressor requirement lead decrease length ICU stay length time intravenous vasopressor require . The investigator plan enroll consent patient onset septic shock . Once IV vasopressor requirement stabilize decreasing , male female randomize 1:1 fashion receive either standard clinical care standard clinical care plus oral midodrine . The investigator analyze length stay ICU , time vasopressor , time needing central line , hospital length stay .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<criteria>â€¢ Patients age 1899 year old Admitted UVA medical ICU diagnosis septic shock . Pregnant female , patient childbearing potential urine pregnancy test consent Patients &lt; 18 year Prisoners Patients already take midodrine Patients cirrhosis ChildPugh Class C ( ChildPugh score &gt; 9 ) _ Patients Increased intraocular pressure glaucoma Patients allergy midodrine NonEnglish speaking patient Patients without enteral access Patients attend physician feel MAP goal &gt; 65 mmHg physiologically acceptable .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>